New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 17  •  04:00PM ET
25.85
Dollar change
+0.17
Percentage change
0.65
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y8.52% Total Holdings253 Perf Week2.53%
SponsorInvesco ETF Type Tagsequity Return% 3Y11.27% AUM41.87M Perf Month6.75%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- NAV/sh Perf Quarter18.20%
IndexNASDAQ Biotechnology Index Average Maturity Tags- Return% 10Y 52W High26.19 -1.28% Perf Half Y30.45%
Index Weighting Commodity Type Tags- Return% SI 52W Low17.84 44.93% Perf YTD20.14%
Active/Passive Quant Type Tags- Flows% 1M3.71% Volatility1.58% 1.20% Perf Year7.86%
Dividend TTM0.23 (0.88%) ESG Type Tags- Flows% 3M7.43% ATR (14)0.35 Perf 3Y34.45%
Dividend Ex-DateSep 22, 2025 Dividend Type Sector/Theme Flows% YTD-6.42% RSI (14)70.73 Perf 5Y-
Dividend Gr. 3/5Y18.46% - Structure Type Region Flows% 1Y Beta0.66 Perf 10Y-
Expense0.19% Growth/Value SMA203.90% Flows% 3Y Rel Volume1.13 Prev Close25.69
Inverse/Leveraged Market Cap SMA507.32% Flows% 5Y Avg Volume10.43K Price25.85
IPOJun 11, 2021 Option/ShortYes / No SMA20016.70% Trades Volume11,761 Change0.65%
Invesco Nasdaq Biotechnology ETF seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index . The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.